Kunkeaw et al. (2023) “A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax” NPJ Vaccines.
DOI: 10.1038/s41541-023-00786-9
Read about Kunkeaw et al. (2023) “A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax” NPJ Vaccines.
Breda et al. (2023) “In vivo hematopoietic stem cell modification by mRNA delivery” Science.
DOI: 10.1126/science.ade6967
Read about Breda et al. (2023) “In vivo hematopoietic stem cell modification by mRNA delivery” Science.
Hoffmann et al. (2023) “ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines” Cell.
DOI: 10.1016/j.cell.2023.04.024
Read about Hoffmann et al. (2023) “ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines” Cell.
Gál et al. (2023) “Restoration of motor function through delayed intraspinal delivery of human IL-10-encoding nucleoside-modified mRNA after spinal cord injury” Research.
DOI: 10.34133/research.0056
Read about Gál et al. (2023) “Restoration of motor function through delayed intraspinal delivery of human IL-10-encoding nucleoside-modified mRNA after spinal cord injury” Research.
Connors et al. (2023) “Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals” Communications Biology.
DOI: 10.1038/s42003-023-04555-1
Read about Connors et al. (2023) “Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals” Communications Biology.
Schiepers et al. (2023) “Molecular fate-mapping of serum antibody responses to repeat immunization” Nature.
DOI: 10.1038/s41586-023-05715-3
Read about Schiepers et al. (2023) “Molecular fate-mapping of serum antibody responses to repeat immunization” Nature.
Arevalo et al. (2022) “A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes” Science.
DOI: 10.1126/science.abm0271
Read about Arevalo et al. (2022) “A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes” Science.
Gorsuch et al. (2022) “Targeting the Hepatitis B cccDNA with a Sequence-Specific ARCUS Nuclease to Eliminate Hepatitis B Virus In Vivo” Molecular Therapy.
DOI: 10.1016/j.ymthe.2022.05.013
Read about Gorsuch et al. (2022) “Targeting the Hepatitis B cccDNA with a Sequence-Specific ARCUS Nuclease to Eliminate Hepatitis B Virus In Vivo” Molecular Therapy.
Pardi et al. (2022) “Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses” Nature Communications.
DOI: 10.1038/s41467-022-32149-8
Read about Pardi et al. (2022) “Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses” Nature Communications.
Mu et al. (2022) “mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice” Cell Reports.
DOI: 10.1016/j.celrep.2022.110514
Read about Mu et al. (2022) “mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice” Cell Reports.
Rurik et al. (2022) “CAR T cells produced in vivo to treat cardiac injury” Science.
DOI: 10.1126/science.abm0594
Read about Rurik et al. (2022) “CAR T cells produced in vivo to treat cardiac injury” Science.
Mallory et al. (2021) “Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice” NPJ Vaccines.
DOI: 10.1038/s41541-021-00345-0
Read about Mallory et al. (2021) “Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice” NPJ Vaccines.